Voltfast | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Voltfast
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Voltfast

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 11 USDMF, 6 CEP/COS, 4 EU WC, 1 KDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

31 API Suppliers
11 USDMF
6 CEP/COS
4 EU WC
1 KDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

115 FDF Dossiers, 26 FDA Orange Book, 20 Europe, 5 Canada, 8 South Africa, 56 Listed Dossiers

115 FDF Dossiers
26 FDA Orange Book
20 Europe
5 Canada
8 South Africa
56 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Rochem International Inc, 18 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 25 BASF, 1 Bioplus Life Sciences, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 39 Direct Compression, 34 Disintegrants & Superdisintegrants, 33 Granulation, 31 Thickeners and Stabilizers, 30 Taste Masking, 26 Solubilizers, 24 Parenteral, 22 Controlled & Modified Release, 20 Film Formers & Plasticizers, 20 Chewable & Orodispersible Aids, 17 Topical, 15 Lubricants & Glidants, 15 Co-Processed Excipients, 9 Empty Capsules, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

77 Fillers, Diluents & Binders
46 Coating Systems & Additives
39 Direct Compression
34 Disintegrants & Superdisintegrants
33 Granulation
31 Thickeners and Stabilizers
30 Taste Masking
26 Solubilizers
24 Parenteral
22 Controlled & Modified Release
20 Film Formers & Plasticizers
20 Chewable & Orodispersible Aids
17 Topical
15 Lubricants & Glidants
15 Co-Processed Excipients
9 Empty Capsules
8 Emulsifying Agents
7 Rheology Modifiers
6 Surfactant & Foaming Agents
6 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 6 Regulatory FDF Prices

18 US Medicaid Prescriptions
6 Regulatory FDF Prices

MARKET PLACE

22 APIs, 5 FDF Dossiers

22 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 2 Health Canada Patents

10 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

1 EDQM
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 17 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Aralez Pharmaceuticals Canada Inc

02 1Riches, McKenzie & Herbert LLP

filter Patent Reset all filters

2 All

01 12254144

02 12932603

filter Product Reset all filters

2 All

01 2Diclofenac Potassium

filter Dosage Reset all filters

2 All

01 2Powder for oral solution

filter Exp Date Reset all filters

2 All

01 12017-05-15

02 12026-06-16

Product Main Page

01

Riches, McKenzie & Herbert L...

Diclofenac Potassium

Pharmaconex

Not Confirmed

Riches, McKenzie & Herbert LLP

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-15

Date Granted : 2007-11-20

Diclofenac Potassium

Brand Name : CAMBIA

Patent Number : 2254144

Filing Date : 1997-05-15

Strength per Unit : 50 mg / sachet

Dosage Form : Powder for oral solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-15

Date Granted : 2007-11-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Aralez Pharmaceuticals Canad...

Diclofenac Potassium

Pharmaconex

Not Confirmed

Aralez Pharmaceuticals Canada Inc

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-16

Date Granted : 2017-08-08

Diclofenac Potassium

Brand Name : CAMBIA

Patent Number : 2932603

Filing Date : 2006-06-16

Strength per Unit : 50 mg / sachet

Dosage Form : Powder for oral solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-06-16

Date Granted : 2017-08-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!